HC Wainwright & Co. Downgrades NeuroSense Therapeutics to Neutral

Benzinga · 3d ago
HC Wainwright & Co. analyst Lander Egaña Gorroño downgrades NeuroSense Therapeutics (NASDAQ:NRSN) from Buy to Neutral.